Distinct from regulation by hypoxia, active phospholipase D2 (PLD2) has been shown to increase expression of EGFR in in breast cancer, in part via stabilization of its mRNA, although a direct mechanism was not identified34. This evidence concerns the gene PLD2 and breast cancer.